LONG-TERM EFFICACY AND TOLERABILITY OF MYCOPHENOLATE MOFETIL THERAPY IN DIFFUSE SCLERODERMA SKIN DISEASE

被引:0
|
作者
Boulos, D. [1 ]
Rajadurai, A. [1 ]
Ngian, G. S. [1 ]
Elford, K. [1 ]
Stevens, W. [2 ]
Proudman, S. [3 ]
Roddy, J. [4 ]
Nikpour, M. [5 ]
Youssef, P. [6 ]
Hill, C. [7 ]
Sahhar, J. [1 ]
机构
[1] Monash Hlth, Rheumatol, Melbourne, Vic, Australia
[2] St Vincents Helath, Rheumatol, Melbourne, Vic, Australia
[3] Royal Adelaide Hosp, Rheumatol, Adelaide, SA, Australia
[4] Royal Perth Hosp, Rheumatol, Perth, WA, Australia
[5] St Vincents Hlth, Rheumatol, Melbourne, Vic, Australia
[6] Royal Prince Alfred Hosp, Rheumatol, Camperdown, NSW, Australia
[7] Queen Elizabeth Hosp, Rheumatol, Woodville, SA, Australia
关键词
D O I
10.1136/annrheumdis-2016-eular.3372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0266
引用
收藏
页码:531 / 531
页数:1
相关论文
共 50 条
  • [1] Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease
    Boulos, Daniel
    Ngian, Gene-Siew
    Rajadurai, Anton
    Elford, Kathleen
    Stevens, Wendy
    Proudman, Susanna
    Owen, Claire
    Roddy, Janet
    Nikpour, Mandana
    Youssef, Peter
    Hill, Catherine
    Sahhar, Joanne
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (04) : 481 - 488
  • [2] Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
    Rezaieyazdi, Zahra
    Tavakoli, Tahmine
    Khajehdaluee, Mohammad
    Honarmand, Shahram
    SPRINGERPLUS, 2014, 3
  • [3] Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome
    Wenzl, HH
    Hinterleitner, TA
    Aichbichler, BW
    Fickert, P
    Petritsch, W
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (04) : 427 - 434
  • [4] MYCOPHENOLATE MOFETIL IN THE TREATMENT OF SCLERODERMA-ASSOCIATED DIFFUSE SKIN DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY
    Rajadurai, A.
    Ngian, G.
    Elford, K.
    Stevens, W.
    Proudman, S.
    Roddy, J.
    Nikpour, M.
    Youssef, P.
    Hill, C.
    Sahhar, J.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 37 - 37
  • [5] Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation
    Lau, CH
    Comer, M
    Lightman, S
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2003, 31 (06): : 487 - 491
  • [6] Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome
    Hervier, Baptiste
    Masseau, Agathe
    Mussini, Jean-Marie
    Audrain, Marie
    Hamidou, Mohamed A.
    JOINT BONE SPINE, 2009, 76 (05) : 575 - 576
  • [7] Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
    Le, Elizabeth N.
    Wigley, Fredrick M.
    Shah, Ami A.
    Boin, Francesco
    Hummers, Laura K.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 1104 - 1107
  • [8] Low efficacy of long-term treatment with mycophenolate mofetil in patients with Crohn's disease.
    Wenzl, HH
    Hinterleitner, TA
    Fickert, P
    Aichbichler, BW
    Metzler, O
    Derler, AM
    Petritsch, W
    GASTROENTEROLOGY, 2000, 118 (04) : A790 - A790
  • [9] Long-term efficacy and safety of maintenance therapy with azathioprine or cyclosporine for interstitial lung disease with diffuse cutaneous scleroderma
    Ando, K.
    Nakashita, T.
    Kaneko, N.
    Takahashi, K.
    Motojima, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (02) : S191 - S192
  • [10] MYCOPHENOLATE MOFETIL USE IN CLINICAL PRACTICE IN A MULTICENTRIC COHORT OF SCLERODERMA PATIENTS: PERSISTENCE ON THERAPY AND LONG-TERM ADVERSE EVENTS
    Verardi, L.
    De Lorenzis, E.
    Pellegrino, G.
    Di Donato, S.
    De Luca, G.
    Campochiaro, C.
    Cacciapaglia, F.
    Lepri, G.
    Cometi, L.
    Armentano, G.
    De Pinto, M.
    Motta, F.
    Cerasuolo, P. G.
    De Santis, M.
    Giuggioli, D.
    Iannone, F.
    Del Papa, N.
    Guiducci, S.
    Riccieri, V.
    Bosello, S. L.
    D'agostino, M. A.
    Del Galdo, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1012 - 1012